| TCF3 |
TCF3, E2A, ITF1: Transcription factor E2-alpha |
HES6 |
HES6: Transcription cofactor HES-6 |
1.132 |
Evidence |
|
| CSF2 |
CSF2, GMCSF: Granulocyte-macrophage colony-stimulating factor precursor |
IL4R |
IL4R, 582J2.1, IL4RA: Interleukin-4 receptor alpha chain precursor |
1.132 |
Evidence |
|
| FADD |
FADD, MORT1: Protein FADD |
EDAR |
EDAR, DL: Tumor necrosis factor receptor superfamily member EDAR precursor |
1.132 |
Evidence |
|
| RASA1 |
RASA1, RASA: Ras GTPase-activating protein 1 |
MATK |
MATK, CTK, HYL: Megakaryocyte-associated tyrosine-protein kinase |
1.132 |
Evidence |
|
| ABL2 |
ABL2, ABLL, ARG: Tyrosine-protein kinase ABL2 |
ITK |
ITK, EMT, LYK: Tyrosine-protein kinase ITK/TSK |
1.132 |
Evidence |
|
| ADRB2 |
ADRB2, ADRB2R, B2AR: Beta-2 adrenergic receptor |
GNAS |
GNAS, GNAS1, GSP: Guanine nucleotide-binding protein G(s) subunit alpha isoforms |
1.132 |
Evidence |
|
| HES6 |
HES6: Transcription cofactor HES-6 |
MLXIPL |
MLXIPL, MIO, WBSCR14: Williams-Beuren syndrome chromosome region 14 protein |
1.132 |
Evidence |
|
| ARNT |
ARNT: Aryl hydrocarbon receptor nuclear translocator |
NCOA3 |
NCOA3, AIB1, RAC3, TRAM1: Nuclear receptor coactivator 3 |
1.132 |
Evidence |
|
| TNFSF12 |
TNFSF13, APRIL, UNQ383/PRO715, TALL2, ZTNF2: Tumor necrosis factor ligand superf |
EDAR |
EDAR, DL: Tumor necrosis factor receptor superfamily member EDAR precursor |
1.132 |
Evidence |
|
| SLC4A3 |
SLC4A3, AE3: Anion exchange protein 3 |
PTPRZ1 |
IPI00291099 |
1.132 |
Evidence |
|
| GNAO1 |
GNAO1: Guanine nucleotide-binding protein G(o) subunit alpha 1 |
F2RL1 |
F2RL1, GPR11, PAR2: Proteinase-activated receptor 2 precursor |
1.132 |
Evidence |
|
| GNA11 |
GNA11, GA11: Guanine nucleotide-binding protein subunit alpha-11 |
C3AR1 |
C3AR1, AZ3B, C3R1, HNFAG09: C3a anaphylatoxin chemotactic receptor |
1.132 |
Evidence |
|
| TGFB1 |
TGFB1, TGFB: Transforming growth factor beta-1 precursor |
NOG |
NOG: Noggin precursor |
1.132 |
Evidence |
|
| GNAI1 |
GNAI1: Guanine nucleotide-binding protein G(i), alpha-1 subunit |
C3AR1 |
C3AR1, AZ3B, C3R1, HNFAG09: C3a anaphylatoxin chemotactic receptor |
1.132 |
Evidence |
|
| DRD2 |
DRD2: D(2) dopamine receptor |
GNA13 |
GNA13: Guanine nucleotide-binding protein alpha-13 subunit |
1.132 |
Evidence |
|
| MATK |
MATK, CTK, HYL: Megakaryocyte-associated tyrosine-protein kinase |
BMX |
IPI00514142 |
1.132 |
Evidence |
|
| GNAZ |
GNAZ: Guanine nucleotide-binding protein G(z) subunit alpha |
EDNRB |
EDNRB, ETRB: Endothelin B receptor precursor |
1.132 |
Evidence |
|
| ABL2 |
ABL2, ABLL, ARG: Tyrosine-protein kinase ABL2 |
FRK |
FRK, PTK5, RAK: Tyrosine-protein kinase FRK |
1.132 |
Evidence |
|
| FYN |
FYN: Proto-oncogene tyrosine-protein kinase Fyn |
PTK6 |
PTK6, BRK: Tyrosine-protein kinase 6 |
1.132 |
Evidence |
|
| MEP1B |
MEP1B: Meprin A subunit beta precursor |
EDAR |
EDAR, DL: Tumor necrosis factor receptor superfamily member EDAR precursor |
1.132 |
Evidence |
|
| ARNT |
ARNT: Aryl hydrocarbon receptor nuclear translocator |
AHR |
AHR: Aryl hydrocarbon receptor precursor |
1.132 |
Evidence |
|
| DNAJC13 |
DNAJC13, KIAA0678, RME8: DnaJ homolog subfamily C member 13 |
RARS |
RARS: Arginyl-tRNA synthetase, cytoplasmic |
1.132 |
Evidence |
|
| MAPK9 |
MAPK9, JNK2, PRKM9: Mitogen-activated protein kinase 9 |
SSH2 |
SSH2, KIAA1725, SSH2L: Protein phosphatase Slingshot homolog 2 |
1.132 |
Evidence |
|
| GNAO1 |
GNAO1: Guanine nucleotide-binding protein G(o) subunit alpha 1 |
FPR1 |
FPR1: fMet-Leu-Phe receptor |
1.132 |
Evidence |
|
| GNAI2 |
Galphai2 protein |
EDNRB |
EDNRB, ETRB: Endothelin B receptor precursor |
1.132 |
Evidence |
|